| CELG Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CELG shares outstanding history going back to 2/11/2010:
Also see: CELG Market Cap History CELG YTD Return |
CELG Shares Outstanding History — Celgene Share Count Over Time
As of 10/29/2019 Celgene has 711.71 million CELG shares outstanding. Investors often track the CELG shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows CELG share count trends over time, with 41 historical shares outstanding datapoints presented, dating back to 2/11/2010.
| CELG Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CELG Historical Shares Outstanding: -2.60% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CELG Stock Price Chart |
| About Bristol Myers Squibb Co. |
| Bristol-Myers Squibb Co. is a biopharmaceutical company engaged in the discovery, development and delivering advanced medicines that help patients prevail over serious diseases. It offers products for various therapeutic classes, which includes oncology, hematology, immunology, cardiovascular and neuroscience. Its pharmaceutical products include chemically synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric antigen receptor (CAR-T) cell therapies. Small molecule drugs are typically administered orally in the form of a tablet or capsule, although other drug delivery mechanisms are used as well. We show 41 historical shares outstanding datapoints in our coverage of CELG's shares outstanding history. Understanding the changing numbers of CELG shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CELG versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CELG by allowing them to research CELG shares outstanding history as well as any other stock in our coverage universe. |
| CELG Current Stock Quote |
Quotes delayed 20 minutes  Free CELG Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| CELG Share Performance |
| Shares Outstanding Peers |
| Celgene (CELG) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CELL Shares Outstanding History CELU Shares Outstanding History CELZ Shares Outstanding History CEMI Shares Outstanding History CERC Shares Outstanding History CERE Shares Outstanding History CERS Shares Outstanding History CFMS Shares Outstanding History CFRX Shares Outstanding History CGEM Shares Outstanding History More Healthcare companies » |
CELG Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
